A detailed history of De Dora Capital, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, De Dora Capital, Inc. holds 11,943 shares of MRK stock, worth $1.22 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
11,943
Previous 13,326 10.38%
Holding current value
$1.22 Million
Previous $1.65 Million 17.77%
% of portfolio
0.4%
Previous 0.52%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$111.15 - $128.97 $153,720 - $178,365
-1,383 Reduced 10.38%
11,943 $1.36 Million
Q2 2024

Jul 17, 2024

SELL
$123.8 - $132.96 $41,225 - $44,275
-333 Reduced 2.44%
13,326 $1.65 Million
Q1 2024

Apr 16, 2024

SELL
$113.24 - $131.95 $370,521 - $431,740
-3,272 Reduced 19.33%
13,659 $1.8 Million
Q4 2023

Jan 18, 2024

SELL
$100.18 - $109.02 $49,889 - $54,291
-498 Reduced 2.86%
16,931 $1.85 Million
Q3 2023

Oct 18, 2023

BUY
$102.95 - $114.33 $66,299 - $73,628
644 Added 3.84%
17,429 $1.79 Million
Q2 2023

Jul 24, 2023

SELL
$108.61 - $118.38 $6,733 - $7,339
-62 Reduced 0.37%
16,785 $1.94 Million
Q1 2023

May 11, 2023

BUY
$102.94 - $114.86 $127,645 - $142,426
1,240 Added 7.95%
16,847 $1.79 Million
Q4 2022

Jan 18, 2023

SELL
$87.44 - $112.11 $24,046 - $30,830
-275 Reduced 1.73%
15,607 $0
Q3 2022

Oct 14, 2022

SELL
$84.53 - $94.96 $46,153 - $51,848
-546 Reduced 3.32%
15,882 $1.37 Million
Q2 2022

Jul 27, 2022

SELL
$83.49 - $94.64 $62,700 - $71,074
-751 Reduced 4.37%
16,428 $1.5 Million
Q1 2022

Apr 14, 2022

BUY
$73.51 - $82.4 $1.26 Million - $1.42 Million
17,179 New
17,179 $1.41 Million
Q4 2021

Jan 18, 2022

SELL
$72.28 - $90.54 $1.22 Million - $1.53 Million
-16,857 Closed
0 $0
Q3 2021

Oct 18, 2021

BUY
$71.68 - $78.83 $53,688 - $59,043
749 Added 4.65%
16,857 $1.27 Million
Q2 2021

Aug 03, 2021

BUY
$70.31 - $77.77 $7,101 - $7,854
101 Added 0.63%
16,108 $1.25 Million
Q1 2021

Apr 27, 2021

SELL
$68.86 - $81.11 $4,407 - $5,191
-64 Reduced 0.4%
16,007 $1.23 Million
Q4 2020

Jan 29, 2021

SELL
$71.77 - $79.65 $186,458 - $206,930
-2,598 Reduced 13.92%
16,071 $1.32 Million
Q3 2020

Oct 20, 2020

BUY
$73.18 - $82.95 $84,157 - $95,392
1,150 Added 6.56%
18,669 $1.55 Million
Q2 2020

Jul 31, 2020

BUY
$70.42 - $80.13 $353,719 - $402,492
5,023 Added 40.2%
17,519 $1.36 Million
Q1 2020

May 04, 2020

BUY
$63.36 - $87.82 $2,661 - $3,688
42 Added 0.34%
12,496 $961,000
Q4 2019

Feb 21, 2020

SELL
$77.58 - $87.54 $417,457 - $471,052
-5,381 Reduced 30.17%
12,454 $1.13 Million
Q3 2019

Oct 22, 2019

BUY
$76.08 - $82.93 $211,122 - $230,130
2,775 Added 18.43%
17,835 $1.5 Million
Q1 2019

Apr 12, 2019

BUY
$69.58 - $79.36 $475,300 - $542,108
6,831 Added 83.01%
15,060 $1.25 Million
Q4 2018

Jan 18, 2019

SELL
$65.24 - $75.71 $35,294 - $40,959
-541 Reduced 6.17%
8,229 $629,000
Q3 2018

Oct 19, 2018

BUY
$57.69 - $67.84 $154,089 - $181,200
2,671 Added 43.79%
8,770 $622,000
Q2 2018

Jul 31, 2018

SELL
$50.83 - $59.72 $18,197 - $21,379
-358 Reduced 5.54%
6,099 $370,000
Q1 2018

Apr 16, 2018

BUY
$50.96 - $59.23 $329,048 - $382,448
6,457 New
6,457 $352,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track De Dora Capital, Inc. Portfolio

Follow De Dora Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of De Dora Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on De Dora Capital, Inc. with notifications on news.